Sonal Sachan, Swastika Suvirya, Krishna Yadav, Prashant Gupta, Abir Saraswat, Parul Verma, Usha Chandra, Balendra Pratap Singh, Shyam Chand Chaudhary, Durgesh Kumar Dwivedi, Ravindra Kumar Garg, Atin Singhai, Kiran Preet Malhotra, Anit Parihar, Saurabh Kumar
Background Cutaneous mucormycosis has shown a significant upsurge during the COVID-19 pandemic. Due to the rapid progression and high mortality of cutaneous mucormycosis in this context, it is important to identify it early. However, very few studies report detailed clinical descriptions of cutaneous mucormycosis in COVID-19 patients. Objectives To describe mucocutaneous lesions of COVID-19-associated mucormycosis based on clinical morphology and attempt to correlate them with radiological changes. Methods A retrospective cross-sectional study was conducted at a tertiary care centre from 1st April to 31st July 2021...
December 13, 2022: Indian Journal of Dermatology, Venereology and Leprology